Literature DB >> 33876971

Four-dimensional Multiphase Steady-State MRI with Ferumoxytol Enhancement: Early Multicenter Feasibility in Pediatric Congenital Heart Disease.

Kim-Lien Nguyen1, Reena M Ghosh1, Lindsay M Griffin1, Takegawa Yoshida1, Arash Bedayat1, Cynthia K Rigsby1, Mark A Fogel1, Kevin K Whitehead1, Peng Hu1, J Paul Finn1.   

Abstract

Background The value of MRI in pediatric congenital heart disease (CHD) is well recognized; however, the requirement for expert oversight impedes its widespread use. Four-dimensional (4D) multiphase steady-state imaging with contrast enhancement (MUSIC) is a cardiovascular MRI technique that uses ferumoxytol and captures all anatomic features dynamically. Purpose To evaluate multicenter feasibility of 4D MUSIC MRI in pediatric CHD. Materials and Methods In this prospective study, participants with CHD underwent 4D MUSIC MRI at 3.0 T or 1.5 T between 2014 and 2020. From a pool of 460 total studies, an equal number of MRI studies from three sites (n = 60) was chosen for detailed analysis. With use of a five-point scale, the feasibility of 4D MUSIC was scored on the basis of artifacts, image quality, and diagnostic confidence for intracardiac and vascular connections (n = 780). Respiratory motion suppression was assessed by using the signal intensity profile. Bias between 4D MUSIC and two-dimensional (2D) cine imaging was evaluated by using Bland-Altman analysis; 4D MUSIC examination duration was compared with that of the local standard for CHD. Results A total of 206 participants with CHD underwent MRI at 3.0 T, and 254 participants underwent MRI at 1.5 T. Of the 60 MRI examinations chosen for analysis (20 per site; median participant age, 14.4 months [interquartile range, 2.3-49 months]; 33 female participants), 56 (93%) had good or excellent image quality scores across a spectrum of disease complexity (mean score ± standard deviation: 4.3 ± 0.6 for site 1, 4.9 ± 0.3 for site 2, and 4.6 ± 0.7 for site 3; P < .001). Artifact scores were inversely related to image quality (r = -0.88, P < .001) and respiratory motion suppression (P < .001, r = -0.45). Diagnostic confidence was high or definite in 730 of 780 (94%) intracardiac and vascular connections. The correlation between 4D MUSIC and 2D cine ventricular volumes and ejection fraction was high (range of r = 0.72-0.85; P < .001 for all). Compared with local standard MRI, 4D MUSIC reduced the image acquisition time (44 minutes ± 20 vs 12 minutes ± 3, respectively; P < .001). Conclusion Four-dimensional multiphase steady-state imaging with contrast enhancement MRI in pediatric congenital heart disease was feasible in a multicenter setting, shortened the examination time, and simplified the acquisition protocol, independently of disease complexity. Clinical trial registration no. NCT02752191 © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Roest and Lamb in this issue.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33876971      PMCID: PMC8248952          DOI: 10.1148/radiol.2021203696

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  21 in total

1.  Respiratory and cardiac self-gated free-breathing cardiac CINE imaging with multiecho 3D hybrid radial SSFP acquisition.

Authors:  Jing Liu; Pascal Spincemaille; Noel C F Codella; Thanh D Nguyen; Martin R Prince; Yi Wang
Journal:  Magn Reson Med       Date:  2010-05       Impact factor: 4.668

Review 2.  Congenital heart disease assessment with 4D flow MRI.

Authors:  Shreyas S Vasanawala; Kate Hanneman; Marcus T Alley; Albert Hsiao
Journal:  J Magn Reson Imaging       Date:  2015-02-24       Impact factor: 4.813

3.  Phase-contrast MRI with hybrid one and two-sided flow-encoding and velocity spectrum separation.

Authors:  Da Wang; Jiaxin Shao; Daniel B Ennis; Peng Hu
Journal:  Magn Reson Med       Date:  2016-08-09       Impact factor: 4.668

4.  Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease.

Authors:  Joseph Y Cheng; Kate Hanneman; Tao Zhang; Marcus T Alley; Peng Lai; Jonathan I Tamir; Martin Uecker; John M Pauly; Michael Lustig; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2015-12-09       Impact factor: 4.813

Review 5.  Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits.

Authors:  J Paul Finn; Kim-Lien Nguyen; Peng Hu
Journal:  J Magn Reson Imaging       Date:  2017-02-03       Impact factor: 5.119

6.  4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease.

Authors:  Kim-Lien Nguyen; Fei Han; Ziwu Zhou; Daniel Z Brunengraber; Ihab Ayad; Daniel S Levi; Gary M Satou; Brian L Reemtsen; Peng Hu; J Paul Finn
Journal:  J Cardiovasc Magn Reson       Date:  2017-04-03       Impact factor: 5.364

7.  Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.

Authors:  Kim-Lien Nguyen; Takegawa Yoshida; Nikhita Kathuria-Prakash; Islam H Zaki; Csanad G Varallyay; Scott I Semple; Rola Saouaf; Cynthia K Rigsby; Sokratis Stoumpos; Kevin K Whitehead; Lindsay M Griffin; David Saloner; Michael D Hope; Martin R Prince; Mark A Fogel; Mark L Schiebler; Giles H Roditi; Aleksandra Radjenovic; David E Newby; Edward A Neuwelt; Mustafa R Bashir; Peng Hu; J Paul Finn
Journal:  Radiology       Date:  2019-10-22       Impact factor: 11.105

8.  MRI with ferumoxytol: A single center experience of safety across the age spectrum.

Authors:  Kim-Lien Nguyen; Takegawa Yoshida; Fei Han; Ihab Ayad; Brian L Reemtsen; Isidro B Salusky; Gary M Satou; Peng Hu; J Paul Finn
Journal:  J Magn Reson Imaging       Date:  2016-08-02       Impact factor: 5.119

9.  Free breathing whole-heart 3D CINE MRI with self-gated Cartesian trajectory.

Authors:  M Usman; B Ruijsink; M S Nazir; G Cruz; C Prieto
Journal:  Magn Reson Imaging       Date:  2016-12-26       Impact factor: 3.130

Review 10.  From Compressed-Sensing to Artificial Intelligence-Based Cardiac MRI Reconstruction.

Authors:  Aurélien Bustin; Niccolo Fuin; René M Botnar; Claudia Prieto
Journal:  Front Cardiovasc Med       Date:  2020-02-25
View more
  2 in total

1.  Contrast-enhanced MR Angiography without Gadolinium-based Contrast Material: Clinical Applications Using Ferumoxytol.

Authors:  Mohammad H Jalili; Tiffany Yu; Cameron Hassani; Ashley E Prosper; J Paul Finn; Arash Bedayat
Journal:  Radiol Cardiothorac Imaging       Date:  2022-08-04

2.  A Two-Photon Microimaging-Microdevice System for Four-Dimensional Imaging of Local Drug Delivery in Tissues.

Authors:  Guigen Liu; Veronica Valvo; Sebastian W Ahn; Devon Thompson; Kyle Deans; Jeon Woong Kang; Sharath Bhagavatula; Christine Dominas; Oliver Jonas
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.